[
  {
    "ts": "2026-02-24T06:06:21+00:00",
    "headline": "Is Abbott Laboratories (ABT) Pricing Reflect Long Term Value After Recent Share Price Weakness",
    "summary": "If you are wondering whether Abbott Laboratories is attractively priced or just fairly valued at current levels, you are not alone. This article will help you put the current share price in context. The stock last closed at US$115.29, with returns of 2.3% over 7 days and 7.3% over 30 days, while year to date and 1 year returns are a 7.2% decline and a 13.0% decline respectively. Recent attention on Abbott has centered on broader healthcare sector sentiment and how large, diversified medical...",
    "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-pricing-reflect-060621495.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "44ce03bd-1fef-324d-bcfc-a00ec2cabaec",
      "content": {
        "id": "44ce03bd-1fef-324d-bcfc-a00ec2cabaec",
        "contentType": "STORY",
        "title": "Is Abbott Laboratories (ABT) Pricing Reflect Long Term Value After Recent Share Price Weakness",
        "description": "",
        "summary": "If you are wondering whether Abbott Laboratories is attractively priced or just fairly valued at current levels, you are not alone. This article will help you put the current share price in context. The stock last closed at US$115.29, with returns of 2.3% over 7 days and 7.3% over 30 days, while year to date and 1 year returns are a 7.2% decline and a 13.0% decline respectively. Recent attention on Abbott has centered on broader healthcare sector sentiment and how large, diversified medical...",
        "pubDate": "2026-02-24T06:06:21Z",
        "displayTime": "2026-02-24T06:06:21Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7zJOBZ6wPnYKbKPRmWh.qQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sc9EgsXKjWnUzlOQpxWhqQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-pricing-reflect-060621495.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-pricing-reflect-060621495.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-24T11:36:00+00:00",
    "headline": "Point of Care Diagnostics Market Competitive Landscape Report 2025 Featuring Top 5 Players - Sysmex, Abbott Laboratories, Becton Dickinson and Co, Danaher, Quidel Diagnostics",
    "summary": "By 2033, the Point of Care (POC) Diagnostics market is projected to reach a valuation of approximately US$ 105.22 billion, driven by an 8.60% CAGR from 2025. This robust growth is fueled by high demand for rapid and accessible testing, escalating global prevalence of infectious diseases, and breakthroughs in technology. POC diagnostics facilitate immediate results at patient care sites, enhancing clinical decision-making and patient outcomes. Key players leading this market, including Sysmex, Ab",
    "url": "https://finance.yahoo.com/news/point-care-diagnostics-market-competitive-113600036.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "e4ebe0fa-a8fe-33f9-95ca-f2ba26235c7d",
      "content": {
        "id": "e4ebe0fa-a8fe-33f9-95ca-f2ba26235c7d",
        "contentType": "STORY",
        "title": "Point of Care Diagnostics Market Competitive Landscape Report 2025 Featuring Top 5 Players - Sysmex, Abbott Laboratories, Becton Dickinson and Co, Danaher, Quidel Diagnostics",
        "description": "",
        "summary": "By 2033, the Point of Care (POC) Diagnostics market is projected to reach a valuation of approximately US$ 105.22 billion, driven by an 8.60% CAGR from 2025. This robust growth is fueled by high demand for rapid and accessible testing, escalating global prevalence of infectious diseases, and breakthroughs in technology. POC diagnostics facilitate immediate results at patient care sites, enhancing clinical decision-making and patient outcomes. Key players leading this market, including Sysmex, Ab",
        "pubDate": "2026-02-24T11:36:00Z",
        "displayTime": "2026-02-24T11:36:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/993317ee30e32c72c2591ec0fc30d3f9",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Point of Care Diagnostics Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wqrHuTmqEsQk2dvWIS8OUQ--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/993317ee30e32c72c2591ec0fc30d3f9.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5qhFABAjc8x7Z53JLslJ3Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/993317ee30e32c72c2591ec0fc30d3f9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/point-care-diagnostics-market-competitive-113600036.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/point-care-diagnostics-market-competitive-113600036.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "6869.T"
            },
            {
              "symbol": "ABT"
            },
            {
              "symbol": "BDX"
            },
            {
              "symbol": "DHR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-24T11:32:00+00:00",
    "headline": "Epilepsy Drugs Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights",
    "summary": "The global epilepsy drugs market is poised for robust growth, estimated to increase from US$ 8.29 billion in 2025 to US$ 11.85 billion by 2033, with a CAGR of 4.57%. Key growth drivers include the rising prevalence of epilepsy, advancements in anti-epileptic medications, and innovative treatment research. Epilepsy drugs, vital for managing seizures, have seen increased global demand due to improved diagnostics and awareness. Major companies like Eisai Co. Ltd., UCB Inc., and Abbott Laboratories",
    "url": "https://finance.yahoo.com/news/epilepsy-drugs-market-competitive-landscape-113200740.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "1e4d0ff8-193d-3f8b-b732-af2a8cc63740",
      "content": {
        "id": "1e4d0ff8-193d-3f8b-b732-af2a8cc63740",
        "contentType": "STORY",
        "title": "Epilepsy Drugs Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights",
        "description": "",
        "summary": "The global epilepsy drugs market is poised for robust growth, estimated to increase from US$ 8.29 billion in 2025 to US$ 11.85 billion by 2033, with a CAGR of 4.57%. Key growth drivers include the rising prevalence of epilepsy, advancements in anti-epileptic medications, and innovative treatment research. Epilepsy drugs, vital for managing seizures, have seen increased global demand due to improved diagnostics and awareness. Major companies like Eisai Co. Ltd., UCB Inc., and Abbott Laboratories",
        "pubDate": "2026-02-24T11:32:00Z",
        "displayTime": "2026-02-24T11:32:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/e53df91220188b04666a906364961530",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Epilepsy Drugs Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fwHxtrWfWyIbt2rWmcAygQ--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/e53df91220188b04666a906364961530.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FzbhLkHn1O5akzKjQyXv3Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/e53df91220188b04666a906364961530.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/epilepsy-drugs-market-competitive-landscape-113200740.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/epilepsy-drugs-market-competitive-landscape-113200740.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "4523.T"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-24T11:30:00+00:00",
    "headline": "Genetic Testing Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Sustainability, Launches, Mergers, Product Innovations, Revenue Insights",
    "summary": "The genetic testing market is set to reach USD 49.72 billion by 2033, expanding at a CAGR of 9.79% from USD 23.55 billion in 2025. Key growth drivers include oncology, rare disease diagnostics, and prenatal testing, underscoring genetic testing's critical role in global healthcare. This surge is propelled by technological advancements and rising consumer awareness, with direct-to-consumer testing becoming more accessible. Companies like Abbott, Illumina, and Roche are at the forefront of this ma",
    "url": "https://finance.yahoo.com/news/genetic-testing-market-competitive-landscape-113000466.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "b7d4126c-3bec-3bc3-b00f-42460233d9fb",
      "content": {
        "id": "b7d4126c-3bec-3bc3-b00f-42460233d9fb",
        "contentType": "STORY",
        "title": "Genetic Testing Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Sustainability, Launches, Mergers, Product Innovations, Revenue Insights",
        "description": "",
        "summary": "The genetic testing market is set to reach USD 49.72 billion by 2033, expanding at a CAGR of 9.79% from USD 23.55 billion in 2025. Key growth drivers include oncology, rare disease diagnostics, and prenatal testing, underscoring genetic testing's critical role in global healthcare. This surge is propelled by technological advancements and rising consumer awareness, with direct-to-consumer testing becoming more accessible. Companies like Abbott, Illumina, and Roche are at the forefront of this ma",
        "pubDate": "2026-02-24T11:30:00Z",
        "displayTime": "2026-02-24T11:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/d9009177d6beb3ff56f1fcc6e337efae",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Genetic Testing Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Y56A1hkchwhg3F4.dnxkpA--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d9009177d6beb3ff56f1fcc6e337efae.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/prlgqYetu5jF2pNeo67vEQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d9009177d6beb3ff56f1fcc6e337efae.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/genetic-testing-market-competitive-landscape-113000466.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/genetic-testing-market-competitive-landscape-113000466.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "ILMN"
            },
            {
              "symbol": "149905998.SW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]